Brain Health Observatory Therapeutic Areas

BHO

Memory care approaches to better leverage capacity of dementia specialists: a narrative synthesis

May 10, 2021

BHO

Is Korea Prepared for an Alzheimer’s Disease-Modifying Therapy? Assessing the Korean Healthcare System Infrastructure and the Effect of Blood-Based Biomarker Tests

February 4, 2021

BHO

Projection of budgetary savings to US state Medicaid programs from reduced nursing home use due to an Alzheimer’s disease treatment

January 1, 2021

BHO

Assessing the Preparedness of the Taiwanese Healthcare System Infrastructure for an Alzheimer’s Treatment

January 1, 2021

BHO

How Much Value Would a Treatment for Alzheimer’s Disease Offer? Cost-Effectiveness Thresholds for Pricing a Disease-Modifying Therapy

January 1, 2020

BHO

Blood-based biomarkers for Alzheimer’s pathology and the diagnostic process for a disease-modifying treatment: Projecting the impact on the cost and wait times

January 1, 2020

BHO

Estimating minimal clinically important differences for two scales in patients with chronic traumatic brain injury

January 1, 2020

BHO

Implications of Alzheimer’s Treatment for Organization and Payment of Medical Practices in Canada

January 1, 2020

BHO

Implications of Alzheimer’s Treatment for Organization and Payment of Medical Practices in the United States

January 1, 2020